You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic syndromes (including PNH)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Acute Myeloid Leukemia, MDS Trial (SPRX002, ARC-T)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • SPRX002
  • ARC-T
  • (no location specified)
Jul 12, 2022

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Algorithm to Assess the Prevalence of PNH-clones

Completed
  • PNH
  • Thrombosis
  • No intervention
  • Roeselare, West-Vlaanderen, Belgium
    AZ Delta
Jun 1, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

A Prospective, Multicentre European Registry for Newly Diagnosed

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • No interventions
  • Innsbruck, Austria
  • +17 more
Dec 28, 2020

MDS, Anemia Trial in Germany (Luspatercept Injection)

Recruiting
  • Myelodysplastic Syndromes
  • Anemia
  • Luspatercept Injection
  • Berlin, Germany
  • +18 more
Jan 25, 2023

Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

Recruiting
  • Iron Deficiency Anemia
  • Adelaide, South Australia, Australia
  • +8 more
Jun 23, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Registry on Hypomethylating Agents in Myeloid Neoplasms

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +2 more
  • non interventional
  • Feldkirch, Austria
  • +19 more
Jul 20, 2021

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

Relapsed / Refractory MDS Trial (NCR300)

Not yet recruiting
  • Relapsed / Refractory Myelodysplastic Syndromes
  • (no location specified)
May 7, 2022

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Inpatient serious illness care program
  • Rochester, New York
    University of Rochester
Jun 21, 2022

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

Completed
  • Relapsed or Refractory Haematological Malignancies Including
  • +10 more
  • Aachen, Germany
  • +11 more
Oct 21, 2021

Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Pevonedistat 25 mg/m^2
  • +4 more
  • Maebashi City, Japan
  • +8 more
Jun 23, 2022

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

The National Myelodysplastic Syndromes (MDS) Study

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • Therapeutic
  • Anaheim, California
  • +280 more
Apr 8, 2022